Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

Dietz A, Wichmann G, Kuhnt T, Pfreundner L, Hagen R, Scheich M, Kölbl O, Hautmann MG, Strutz J, Schreiber F, Bockmühl U, et al. (2018)
Annals of Oncology 29(10): 2105-2114.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Dietz, A.; Wichmann, G.; Kuhnt, T.; Pfreundner, L.; Hagen, R.; Scheich, M.; Kölbl, O.; Hautmann, M.G.; Strutz, J.; Schreiber, F.; Bockmühl, U.; Schilling, V.
Alle
Erscheinungsjahr
2018
Zeitschriftentitel
Annals of Oncology
Band
29
Ausgabe
10
Seite(n)
2105-2114
ISSN
09237534
Page URI
https://pub.uni-bielefeld.de/record/2951839

Zitieren

Dietz A, Wichmann G, Kuhnt T, et al. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. Annals of Oncology. 2018;29(10):2105-2114.
Dietz, A., Wichmann, G., Kuhnt, T., Pfreundner, L., Hagen, R., Scheich, M., Kölbl, O., et al. (2018). Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. Annals of Oncology, 29(10), 2105-2114. https://doi.org/10.1093/annonc/mdy332
Dietz, A., Wichmann, G., Kuhnt, T., Pfreundner, L., Hagen, R., Scheich, M., Kölbl, O., Hautmann, M. G., Strutz, J., Schreiber, F., et al. (2018). Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. Annals of Oncology 29, 2105-2114.
Dietz, A., et al., 2018. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. Annals of Oncology, 29(10), p 2105-2114.
A. Dietz, et al., “Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II”, Annals of Oncology, vol. 29, 2018, pp. 2105-2114.
Dietz, A., Wichmann, G., Kuhnt, T., Pfreundner, L., Hagen, R., Scheich, M., Kölbl, O., Hautmann, M.G., Strutz, J., Schreiber, F., Bockmühl, U., Schilling, V., Feyer, P., de Wit, M., Maschmeyer, G., Jungehülsing, M., Schroeder, U., Wollenberg, B., Sittel, C., Münter, M., Lenarz, T., Klussmann, J.P., Guntinas-Lichius, O., Rudack, C., Eich, H.T., Foerg, T., Preyer, S., Westhofen, M., Welkoborsky, H.J., Esser, D., Thurnher, D., Remmert, S., Sudhoff, H., Görner, M., Bünzel, J., Budach, V., Held, S., Knödler, M., Lordick, F., Wiegand, S., Vogel, K., Boehm, A., Flentje, M., Keilholz, U.: Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. Annals of Oncology. 29, 2105-2114 (2018).
Dietz, A., Wichmann, G., Kuhnt, T., Pfreundner, L., Hagen, R., Scheich, M., Kölbl, O., Hautmann, M.G., Strutz, J., Schreiber, F., Bockmühl, U., Schilling, V., Feyer, P., de Wit, M., Maschmeyer, G., Jungehülsing, M., Schroeder, U., Wollenberg, B., Sittel, C., Münter, M., Lenarz, T., Klussmann, J.P., Guntinas-Lichius, O., Rudack, C., Eich, H.T., Foerg, T., Preyer, S., Westhofen, M., Welkoborsky, H.J., Esser, D., Thurnher, D., Remmert, S., Sudhoff, Holger, Görner, M., Bünzel, J., Budach, V., Held, S., Knödler, M., Lordick, F., Wiegand, S., Vogel, K., Boehm, A., Flentje, M., and Keilholz, U. “Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II”. Annals of Oncology 29.10 (2018): 2105-2114.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 30412221
PubMed | Europe PMC

Suchen in

Google Scholar